Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Allele Traits

Multiple Allele Traits

The Concept of Multiple Allelism

Oxygen Transport in the Blood

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...

Hypoxia

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Histopathological observations in the brains of children exposed to inhalational anesthetic agents: a retrospective autopsy-based study.

Minerva anestesiologica·2015

Same author

Extending the WHO 'Safe Surgery Saves Lives' project through Global Oximetry.

Anaesthesia·2009

Same author

Bcl2 phosphorylation and active PKC alpha are associated with poor survival in AML.

Leukemia·2006

Same author

Multiple hyperbaric oxygenation (HBO) expands the therapeutic window in acute spinal cord injury in rats.

Acta neurochirurgica. Supplement·2004

Same author

Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels.

Leukemia & lymphoma·2002

Same author

Neuroendocrine tumors of the genital tract.

American journal of clinical pathology·2002

Search research articles

Related Experiment Video

Updated: Jul 23, 2026

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

In vitro effects of hyperbaric oxygen on sickle cell morphology.

G Mychaskiw¹, S A Woodyard, C D Brunson

¹University of Mississippi School of Medicine, 2500 North State Street, Jackson, MS 39216-4505, USA. gmychaskiw@anesthesia.umsmed.edu

Journal of Clinical Anesthesia

|July 4, 2001

Summary

Hyperbaric oxygen did not alter sickle cell morphology in vitro. Further in vivo studies are needed to explore potential clinical benefits for sickle cell crisis.

More Related Videos

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

Affordable Oxygen Microscopy-Assisted Biofabrication of Multicellular Spheroids

Affordable Oxygen Microscopy-Assisted Biofabrication of Multicellular Spheroids

Published on: April 6, 2022

Related Experiment Videos

Last Updated: Jul 23, 2026

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

Affordable Oxygen Microscopy-Assisted Biofabrication of Multicellular Spheroids

Affordable Oxygen Microscopy-Assisted Biofabrication of Multicellular Spheroids

Published on: April 6, 2022

Area of Science:

Hematology
Oxygen Therapy
Cell Biology

Background:

Sickle cell disease is a genetic blood disorder characterized by abnormal hemoglobin.
Sickle cell morphology is a key factor in disease pathology and vaso-occlusive crises.
Hyperbaric oxygen therapy (HBOT) has shown potential clinical benefits in sickle cell crisis, but its direct effect on cell morphology is unclear.

Purpose of the Study:

To investigate the in vitro effect of hyperbaric oxygen on the morphology of sickle cells.
To determine if hyperbaric oxygen exposure can alter the characteristic sickle shape of red blood cells.

Main Methods:

Prospective in vitro study involving blood samples from 10 children with homozygous sickle cell disease.
Blood samples were exposed to 100% oxygen at 3 atmospheres absolute pressure for 15 minutes.
Morphological changes were assessed by blinded technicians, comparing hyperbaric oxygen-exposed samples to controls.

Main Results:

Hyperbaric oxygen exposure showed no significant effect on sickle cell morphology.
The percentages of normal cells, sickle cells, and other sickle forms remained unchanged after hyperbaric oxygen treatment.
Quantitative analysis using t-tests confirmed the lack of morphological alteration.

Conclusions:

Hyperbaric oxygen does not appear to alter sickle cell morphology in an in vitro setting.
The observed clinical benefits of HBOT in sickle cell crisis may be mediated by mechanisms other than direct morphological changes.
Further in vivo studies are warranted to fully elucidate the role of HBOT in managing sickle cell disease.